Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Kristen Fortney

At a glance: Kristen Fortney is CEO at BioAge Labs (BIOA). Their latest SEC Form 4, filed Jan 15, 2026, reported a sale of $4.2M. On file: 0 purchase lines ($0) and 1 sale line ($4.2M).

Disclosed holdings: about $4.3M of BIOA stock: 976,949 shares reported on their latest Form 4 (filed Jan 15, 2026), valued at the Nov 20, 2026 close of $4.36. This counts only BIOA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO at BioAge Labs, Inc. (BIOA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.2M

Reported trades

Filed Stock Type Shares Price Value Since
Jan 15SEC BIOABioAge Labs, Inc. Sell Plan 233,107976,949 held (−19%) $18.12 $4.2M -75.9%
  • Sell

    CEO Kristen Fortney sold $4.2M of BIOA at $18.12 — pre-scheduled 10b5-1 plan sale.

Follow Kristen Fortney

Get one email when Kristen Fortney files a new purchase or sale. Free.

At most one email a day about Kristen Fortney, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.